You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rimiducid

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy Trial in Pavia, Rome, Turin (BPX-501 T cells, rimiducid)

Active, not recruiting
  • Hematologic Malignancy
  • BPX-501 T cells
  • rimiducid
  • Pavia, Italy
  • +2 more
Jul 10, 2022

Solid Tumors Trial in Houston (Rimiducid, TROP2-CAR-NK Cells, Fludarabine phosphate)

Not yet recruiting
  • Solid Tumors
  • Rimiducid
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

Acute Lymphoblastic Leukemia, Immune System Diseases, Immunoproliferative Disorders Trial in Chapel Hill (iC9-CAR19 cells,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • iC9-CAR19 cells
  • +3 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 21, 2022

Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • P-CD19CD20-ALLO1
  • Rimiducid
  • La Jolla, California
  • +7 more
Aug 25, 2023

Breast Cancer, Ovarian Cancer, Non Small Cell Lung Cancer Trial in San Francisco, Denver, San Antonio (P-MUC1C-ALLO1 CAR-T

Recruiting
  • Breast Cancer
  • +8 more
  • P-MUC1C-ALLO1 CAR-T cells
  • Rimiducid
  • San Francisco, California
  • +4 more
Oct 26, 2022

Myeloma-Multiple, Myeloma, Plasma-Cell Trial run by the NCI (Cyclophosphamide, Fludarabine, Rimiducid)

Completed
Has Results
  • Myeloma-Multiple
  • Myeloma, Plasma-Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 19, 2021

Multiple Myeloma Trial in United States (P-BCMA-101 CAR-T cells, Rimiducid)

Terminated
  • Multiple Myeloma
  • P-BCMA-101 CAR-T cells
  • Rimiducid
  • Gilbert, Arizona
  • +15 more
May 17, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Hurler Syndrome, Inherited Metabolic Disorder, Lysosomal Storage Disorder Trial in Los Angeles, Palo Alto (rivogenlecleucel,

No longer available
  • Hurler Syndrome
  • +4 more
  • rivogenlecleucel
  • rimiducid
  • Los Angeles, California
  • +1 more
Oct 1, 2020

Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • +16 more
  • P-PSMA-101 CAR-T cells
  • Rimiducid
  • Duarte, California
  • +9 more
Nov 15, 2022

Leukemia, MDS, Lymphomas Trial (rivogenlecleucel, Rimiducid)

Withdrawn
  • Leukemia
  • +4 more
  • rivogenlecleucel
  • Rimiducid
  • (no location specified)
Oct 1, 2020

Acute Myeloid Leukemia, MDS Trial in Nashville, San Antonio (biological, drug, procedure)

Terminated
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • rivogenlecleucel
  • +3 more
  • Nashville, Tennessee
  • +1 more
Nov 11, 2020

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Uveal Melanoma Trial in Denver, Portland, Nashville (BPX-701, Rimiducid)

Unknown status
  • Acute Myeloid Leukemia
  • +2 more
  • BPX-701
  • Rimiducid
  • Denver, Colorado
  • +2 more
Apr 23, 2020

Acute Bilineal Leukemia, Myelodysplastic/Myeloproliferative Tumor, Myelodysplastic/Myeloproliferative Tumor, Unclassifiable

Withdrawn
  • Acute Bilineal Leukemia
  • +11 more
  • Rivogenlecleucel
  • Rimiducid
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 12, 2020